| Primary |
| Hepatitis C |
48.3% |
| Malignant Melanoma Stage Iii |
8.6% |
| Chronic Hepatitis C |
6.9% |
| Prophylaxis Of Nausea And Vomiting |
6.9% |
| Hypertension |
3.4% |
| Malignant Melanoma |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Prophylaxis |
3.4% |
| Allergic Granulomatous Angiitis |
1.7% |
| Blood Urea Increased |
1.7% |
| Carcinoma |
1.7% |
| Diabetes Mellitus |
1.7% |
| Dyspnoea |
1.7% |
| Hepatitis C Virus Test Positive |
1.7% |
| Mycosis Fungoides |
1.7% |
| Polycythaemia Vera |
1.7% |
| Varices Oesophageal |
1.7% |
|
| Hypoglycaemia |
8.0% |
| Suicidal Ideation |
8.0% |
| Therapeutic Response Decreased |
8.0% |
| Vomiting |
8.0% |
| Weight Decreased |
8.0% |
| Adverse Drug Reaction |
4.0% |
| Cardiac Disorder |
4.0% |
| Chest Pain |
4.0% |
| Diabetic Ketoacidosis |
4.0% |
| Dizziness |
4.0% |
| Erythema Multiforme |
4.0% |
| Hyperthyroidism |
4.0% |
| Hypothyroidism |
4.0% |
| Infection |
4.0% |
| Myoclonic Epilepsy |
4.0% |
| Nasopharyngitis |
4.0% |
| Oxygen Saturation Decreased |
4.0% |
| Platelet Count Increased |
4.0% |
| Platelet Toxicity |
4.0% |
| Pyoderma Gangrenosum |
4.0% |
|
| Secondary |
| Hepatitis C |
47.7% |
| Malignant Melanoma |
6.1% |
| Vitamin Supplementation |
5.4% |
| Metastatic Malignant Melanoma |
5.2% |
| Drug Use For Unknown Indication |
4.7% |
| Metastatic Renal Cell Carcinoma |
3.6% |
| Mantle Cell Lymphoma |
3.3% |
| B-cell Lymphoma |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Hiv Infection |
2.5% |
| Adult T-cell Lymphoma/leukaemia |
2.2% |
| Chronic Hepatitis C |
2.0% |
| Hepatic Cirrhosis |
1.8% |
| Diffuse Large B-cell Lymphoma |
1.6% |
| Hypertension |
1.6% |
| Malignant Melanoma Stage Iv |
1.4% |
| Testicular Germ Cell Cancer |
1.4% |
| Diabetes Mellitus |
1.3% |
| Nausea |
1.3% |
| Prophylaxis |
1.3% |
|
| Hepatic Neoplasm Malignant |
22.4% |
| Weight Decreased |
9.5% |
| White Blood Cell Count Decreased |
8.6% |
| Swelling Face |
7.8% |
| Vomiting |
7.8% |
| Parkinsonism |
4.3% |
| Rash |
4.3% |
| Hypocalcaemia |
3.4% |
| Sepsis |
3.4% |
| Zygomycosis |
3.4% |
| Anaemia |
2.6% |
| Folliculitis |
2.6% |
| Hepatitis |
2.6% |
| Ischaemic Stroke |
2.6% |
| Oesophageal Carcinoma |
2.6% |
| Pancytopenia |
2.6% |
| Syncope |
2.6% |
| Tooth Loss |
2.6% |
| Vogt-koyanagi-harada Syndrome |
2.6% |
| Arthralgia |
1.7% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
28.6% |
| Hepatitis C |
23.2% |
| Prophylaxis |
8.9% |
| Diabetes Mellitus |
3.6% |
| Hepatitis B |
3.6% |
| Hepatitis B Positive |
3.6% |
| Hypertension |
3.6% |
| Metastatic Malignant Melanoma |
3.6% |
| Thrombocytopenia |
3.6% |
| Anaemia |
2.7% |
| Drug Use For Unknown Indication |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Liver Transplant |
1.8% |
| Malignant Melanoma |
1.8% |
| Renal Cell Carcinoma Stage Unspecified |
1.8% |
| Chronic Myeloid Leukaemia |
0.9% |
| Colitis Ulcerative |
0.9% |
| Dyslipidaemia |
0.9% |
| Infection |
0.9% |
| Insomnia |
0.9% |
|
| Osteonecrosis |
14.7% |
| Acne |
8.8% |
| Vomiting |
8.8% |
| Interstitial Lung Disease |
5.9% |
| Nervous System Disorder |
5.9% |
| Oedema Peripheral |
5.9% |
| Rash |
5.9% |
| Thrombocytopenia |
5.9% |
| Urine Bilirubin Increased |
5.9% |
| Abdominal Pain |
2.9% |
| Anaemia |
2.9% |
| Blood Creatinine Increased |
2.9% |
| Bone Disorder |
2.9% |
| Calculus Ureteric |
2.9% |
| Cough |
2.9% |
| Cytomegalovirus Infection |
2.9% |
| Death |
2.9% |
| Electrocardiogram T Wave Abnormal |
2.9% |
| Flank Pain |
2.9% |
| Hot Flush |
2.9% |
|
